Imaging Tests
The researchers establish that amyloid protein deposits associate greatly with heart malignancy. Heart malignancy results in congestive heart failure at later stages of amyloidosis; this condition terms as Cardiac Amyloidosis. Cardiac biomarker like NT-ProBNP indicates the ventricular dysfunction causing due to an increase in the heart walls stress. This indication can help in the early treatment of heart failure.
An Echocardiogram is also a must step in the assessment of the extent of heart damage. This image screening gives the proper insight into the size and functioning of the heart. The ventricular dysfunction and other blockages in the arteries are also visible in this imaging test. Early diagnosis through cardiac biomarkers can help in the early treatment and a better survival rate of the patients.